img

Global Risperidone Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Risperidone Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Risperdal (generic name risperidone) is an antipsychotic drug prescribed to treat schizophrenia, bipolar disorder and some behavioral problems in children with autism. It works by changing the effects of chemicals in the brain. It rebalances dopamine and serotonin to potentially improve mood, behavior and thinking.
The global Risperidone market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Risperidone is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The China market for Risperidone is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The Europe market for Risperidone is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034..
The global key manufacturers of Risperidone include Pharaonia Pharmaceuticals, Aurobindo Pharma, Wellona Pharma, Hikma Pharmaceuticals, Janssen Pharmaceuticals, Amneal Pharmaceuticals and Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd., etc. In 2024, the global top five players hold a share approximately % in sales volume, and in term of revenue of Risperidone, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Risperidone by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global Risperidone market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Risperidone market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Pharaonia Pharmaceuticals
Aurobindo Pharma
Wellona Pharma
Hikma Pharmaceuticals
Janssen Pharmaceuticals
Amneal Pharmaceuticals
Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd.
By Type
Tablets
Solution
Others
By Application
Hospital
Clinic
Others
Sales by Region
North America
United States
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Risperidone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Risperidone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Risperidone sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Risperidone Definition
1.2 Market by Type
1.2.1 Global Risperidone Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Tablets
1.2.3 Solution
1.2.4 Others
1.3 Market Segment by Application
1.3.1 Global Risperidone Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Risperidone Sales
2.1 Global Risperidone Revenue Estimates and Forecasts 2018-2034
2.2 Global Risperidone Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Risperidone Revenue by Region
2.3.1 Global Risperidone Revenue by Region (2018-2023)
2.3.2 Global Risperidone Revenue by Region (2024-2034)
2.4 Global Risperidone Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Risperidone Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Risperidone Sales Quantity by Region
2.6.1 Global Risperidone Sales Quantity by Region (2018-2023)
2.6.2 Global Risperidone Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Risperidone Sales Quantity by Manufacturers
3.1.1 Global Risperidone Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Risperidone Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Risperidone Sales in 2024
3.2 Global Risperidone Revenue by Manufacturers
3.2.1 Global Risperidone Revenue by Manufacturers (2018-2023)
3.2.2 Global Risperidone Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Risperidone Revenue in 2024
3.3 Global Risperidone Sales Price by Manufacturers
3.4 Global Key Players of Risperidone, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Risperidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Risperidone, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Risperidone, Product Offered and Application
3.8 Global Key Manufacturers of Risperidone, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Risperidone Sales Quantity by Type
4.1.1 Global Risperidone Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Risperidone Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Risperidone Sales Quantity Market Share by Type (2018-2034)
4.2 Global Risperidone Revenue by Type
4.2.1 Global Risperidone Historical Revenue by Type (2018-2023)
4.2.2 Global Risperidone Forecasted Revenue by Type (2024-2034)
4.2.3 Global Risperidone Revenue Market Share by Type (2018-2034)
4.3 Global Risperidone Price by Type
4.3.1 Global Risperidone Price by Type (2018-2023)
4.3.2 Global Risperidone Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Risperidone Sales Quantity by Application
5.1.1 Global Risperidone Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Risperidone Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Risperidone Sales Quantity Market Share by Application (2018-2034)
5.2 Global Risperidone Revenue by Application
5.2.1 Global Risperidone Historical Revenue by Application (2018-2023)
5.2.2 Global Risperidone Forecasted Revenue by Application (2024-2034)
5.2.3 Global Risperidone Revenue Market Share by Application (2018-2034)
5.3 Global Risperidone Price by Application
5.3.1 Global Risperidone Price by Application (2018-2023)
5.3.2 Global Risperidone Price Forecast by Application (2024-2034)
6 North America
6.1 North America Risperidone Sales by Company
6.1.1 North America Risperidone Revenue by Company (2018-2023)
6.1.2 North America Risperidone Sales Quantity by Company (2018-2023)
6.2 North America Risperidone Market Size by Type
6.2.1 North America Risperidone Sales Quantity by Type (2018-2034)
6.2.2 North America Risperidone Revenue by Type (2018-2034)
6.3 North America Risperidone Market Size by Application
6.3.1 North America Risperidone Sales Quantity by Application (2018-2034)
6.3.2 North America Risperidone Revenue by Application (2018-2034)
6.4 North America Risperidone Market Size by Country
6.4.1 North America Risperidone Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Risperidone Revenue by Country (2018-2034)
6.4.3 North America Risperidone Sales Quantity by Country (2018-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Risperidone Sales by Company
7.1.1 Europe Risperidone Sales Quantity by Company (2018-2023)
7.1.2 Europe Risperidone Revenue by Company (2018-2023)
7.2 Europe Risperidone Market Size by Type
7.2.1 Europe Risperidone Sales Quantity by Type (2018-2034)
7.2.2 Europe Risperidone Revenue by Type (2018-2034)
7.3 Europe Risperidone Market Size by Application
7.3.1 Europe Risperidone Sales Quantity by Application (2018-2034)
7.3.2 Europe Risperidone Revenue by Application (2018-2034)
7.4 Europe Risperidone Market Size by Country
7.4.1 Europe Risperidone Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Risperidone Revenue by Country (2018-2034)
7.4.3 Europe Risperidone Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Risperidone Sales by Company
8.1.1 China Risperidone Sales Quantity by Company (2018-2023)
8.1.2 China Risperidone Revenue by Company (2018-2023)
8.2 China Risperidone Market Size by Type
8.2.1 China Risperidone Sales Quantity by Type (2018-2034)
8.2.2 China Risperidone Revenue by Type (2018-2034)
8.3 China Risperidone Market Size by Application
8.3.1 China Risperidone Sales Quantity by Application (2018-2034)
8.3.2 China Risperidone Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Risperidone Sales by Company
9.1.1 APAC Risperidone Sales Quantity by Company (2018-2023)
9.1.2 APAC Risperidone Revenue by Company (2018-2023)
9.2 APAC Risperidone Market Size by Type
9.2.1 APAC Risperidone Sales Quantity by Type (2018-2034)
9.2.2 APAC Risperidone Revenue by Type (2018-2034)
9.3 APAC Risperidone Market Size by Application
9.3.1 APAC Risperidone Sales Quantity by Application (2018-2034)
9.3.2 APAC Risperidone Revenue by Application (2018-2034)
9.4 APAC Risperidone Market Size by Region
9.4.1 APAC Risperidone Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Risperidone Revenue by Region (2018-2034)
9.4.3 APAC Risperidone Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Risperidone Sales by Company
10.1.1 Middle East, Africa and Latin America Risperidone Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Risperidone Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Risperidone Market Size by Type
10.2.1 Middle East, Africa and Latin America Risperidone Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Risperidone Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Risperidone Market Size by Application
10.3.1 Middle East, Africa and Latin America Risperidone Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Risperidone Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Risperidone Market Size by Country
10.4.1 Middle East, Africa and Latin America Risperidone Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Risperidone Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Risperidone Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Pharaonia Pharmaceuticals
11.1.1 Pharaonia Pharmaceuticals Company Information
11.1.2 Pharaonia Pharmaceuticals Overview
11.1.3 Pharaonia Pharmaceuticals Risperidone Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Pharaonia Pharmaceuticals Risperidone Products and Services
11.1.5 Pharaonia Pharmaceuticals Risperidone SWOT Analysis
11.1.6 Pharaonia Pharmaceuticals Recent Developments
11.2 Aurobindo Pharma
11.2.1 Aurobindo Pharma Company Information
11.2.2 Aurobindo Pharma Overview
11.2.3 Aurobindo Pharma Risperidone Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Aurobindo Pharma Risperidone Products and Services
11.2.5 Aurobindo Pharma Risperidone SWOT Analysis
11.2.6 Aurobindo Pharma Recent Developments
11.3 Wellona Pharma
11.3.1 Wellona Pharma Company Information
11.3.2 Wellona Pharma Overview
11.3.3 Wellona Pharma Risperidone Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Wellona Pharma Risperidone Products and Services
11.3.5 Wellona Pharma Risperidone SWOT Analysis
11.3.6 Wellona Pharma Recent Developments
11.4 Hikma Pharmaceuticals
11.4.1 Hikma Pharmaceuticals Company Information
11.4.2 Hikma Pharmaceuticals Overview
11.4.3 Hikma Pharmaceuticals Risperidone Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Hikma Pharmaceuticals Risperidone Products and Services
11.4.5 Hikma Pharmaceuticals Risperidone SWOT Analysis
11.4.6 Hikma Pharmaceuticals Recent Developments
11.5 Janssen Pharmaceuticals
11.5.1 Janssen Pharmaceuticals Company Information
11.5.2 Janssen Pharmaceuticals Overview
11.5.3 Janssen Pharmaceuticals Risperidone Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Janssen Pharmaceuticals Risperidone Products and Services
11.5.5 Janssen Pharmaceuticals Risperidone SWOT Analysis
11.5.6 Janssen Pharmaceuticals Recent Developments
11.6 Amneal Pharmaceuticals
11.6.1 Amneal Pharmaceuticals Company Information
11.6.2 Amneal Pharmaceuticals Overview
11.6.3 Amneal Pharmaceuticals Risperidone Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Amneal Pharmaceuticals Risperidone Products and Services
11.6.5 Amneal Pharmaceuticals Risperidone SWOT Analysis
11.6.6 Amneal Pharmaceuticals Recent Developments
11.7 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd.
11.7.1 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Company Information
11.7.2 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Overview
11.7.3 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Risperidone Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Risperidone Products and Services
11.7.5 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Risperidone SWOT Analysis
11.7.6 Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Risperidone Value Chain Analysis
12.2 Risperidone Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Risperidone Production Mode & Process
12.4 Risperidone Sales and Marketing
12.4.1 Risperidone Sales Channels
12.4.2 Risperidone Distributors
12.5 Risperidone Customers
13 Market Dynamics
13.1 Risperidone Industry Trends
13.2 Risperidone Market Drivers
13.3 Risperidone Market Challenges
13.4 Risperidone Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Risperidone Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Tablets
Table 3. Major Manufacturers of Solution
Table 4. Major Manufacturers of Others
Table 5. Global Risperidone Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Risperidone Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global Risperidone Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Risperidone Revenue Market Share by Region (2018-2023)
Table 9. Global Risperidone Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Risperidone Revenue Market Share by Region (2024-2034)
Table 11. Global Risperidone Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Units)
Table 12. Global Risperidone Sales by Region (2018-2023) & (K Units)
Table 13. Global Risperidone Sales Market Share by Region (2018-2023)
Table 14. Global Risperidone Sales by Region (2024-2034) & (K Units)
Table 15. Global Risperidone Sales Market Share by Region (2024-2034)
Table 16. Global Risperidone Sales Quantity by Manufacturers (2018-2023) & (K Units)
Table 17. Global Risperidone Sales Quantity Share by Manufacturers (2018-2023)
Table 18. Global Risperidone Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global Risperidone Revenue Share by Manufacturers (2018-2023)
Table 20. Global Risperidone Price by Manufacturers 2018-2023 (US$/Unit)
Table 21. Global Key Players of Risperidone, Industry Ranking, 2021 VS 2024
Table 22. Global Risperidone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Risperidone by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Risperidone as of 2024)
Table 24. Global Key Manufacturers of Risperidone, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Risperidone, Product Offered and Application
Table 26. Global Key Manufacturers of Risperidone, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Risperidone Sales Quantity by Type (2018-2023) & (K Units)
Table 29. Global Risperidone Sales Quantity by Type (2024-2034) & (K Units)
Table 30. Global Risperidone Sales Quantity Share by Type (2018-2023)
Table 31. Global Risperidone Sales Quantity Share by Type (2024-2034)
Table 32. Global Risperidone Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global Risperidone Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Risperidone Revenue Share by Type (2018-2023)
Table 35. Global Risperidone Revenue Share by Type (2024-2034)
Table 36. Risperidone Price by Type (2018-2023) & (US$/Unit)
Table 37. Global Risperidone Price Forecast by Type (2024-2034) & (US$/Unit)
Table 38. Global Risperidone Sales Quantity by Application (2018-2023) & (K Units)
Table 39. Global Risperidone Sales Quantity by Application (2024-2034) & (K Units)
Table 40. Global Risperidone Sales Quantity Share by Application (2018-2023)
Table 41. Global Risperidone Sales Quantity Share by Application (2024-2034)
Table 42. Global Risperidone Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global Risperidone Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Risperidone Revenue Share by Application (2018-2023)
Table 45. Global Risperidone Revenue Share by Application (2024-2034)
Table 46. Risperidone Price by Application (2018-2023) & (US$/Unit)
Table 47. Global Risperidone Price Forecast by Application (2024-2034) & (US$/Unit)
Table 48. North America Risperidone Revenue by Company (2018-2023) & (US$ Million)
Table 49. North America Risperidone Sales Quantity by Company (2018-2023) & (K Units)
Table 50. North America Risperidone Sales Quantity by Type (2018-2023) & (K Units)
Table 51. North America Risperidone Sales Quantity by Type (2024-2034) & (K Units)
Table 52. North America Risperidone Revenue by Type (2018-2023) & (US$ Million)
Table 53. North America Risperidone Revenue by Type (2024-2034) & (US$ Million)
Table 54. North America Risperidone Sales Quantity by Application (2018-2023) & (K Units)
Table 55. North America Risperidone Sales Quantity by Application (2024-2034) & (K Units)
Table 56. North America Risperidone Revenue by Application (2018-2023) & (US$ Million)
Table 57. North America Risperidone Revenue by Application (2024-2034) & (US$ Million)
Table 58. North America Risperidone Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 59. North America Risperidone Revenue by Country (2018-2023) & (US$ Million)
Table 60. North America Risperidone Revenue by Country (2024-2034) & (US$ Million)
Table 61. North America Risperidone Sales Quantity by Country (2018-2023) & (K Units)
Table 62. North America Risperidone Sales Quantity by Country (2024-2034) & (K Units)
Table 63. Europe Risperidone Sales Quantity by Company (2018-2023) & (K Units)
Table 64. Europe Risperidone Revenue by Company (2018-2023) & (US$ Million)
Table 65. Europe Risperidone Sales Quantity by Type (2018-2023) & (K Units)
Table 66. Europe Risperidone Sales Quantity by Type (2024-2034) & (K Units)
Table 67. Europe Risperidone Revenue by Type (2018-2023) & (US$ Million)
Table 68. Europe Risperidone Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe Risperidone Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Europe Risperidone Sales Quantity by Application (2024-2034) & (K Units)
Table 71. Europe Risperidone Revenue by Application (2018-2023) & (US$ Million)
Table 72. Europe Risperidone Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe Risperidone Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 74. Europe Risperidone Revenue by Country (2018-2023) & (US$ Million)
Table 75. Europe Risperidone Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe Risperidone Sales Quantity by Country (2018-2023) & (K Units)
Table 77. Europe Risperidone Sales Quantity by Country (2024-2034) & (K Units)
Table 78. China Risperidone Sales Quantity by Company (2018-2023) & (K Units)
Table 79. China Risperidone Revenue by Company (2018-2023) & (US$ Million)
Table 80. China Risperidone Sales Quantity by Type (2018-2023) & (K Units)
Table 81. China Risperidone Sales Quantity by Type (2024-2034) & (K Units)
Table 82. China Risperidone Revenue by Type (2018-2023) & (US$ Million)
Table 83. China Risperidone Revenue by Type (2024-2034) & (US$ Million)
Table 84. China Risperidone Sales Quantity by Application (2018-2023) & (K Units)
Table 85. China Risperidone Sales Quantity by Application (2024-2034) & (K Units)
Table 86. China Risperidone Revenue by Application (2018-2023) & (US$ Million)
Table 87. China Risperidone Revenue by Application (2024-2034) & (US$ Million)
Table 88. APAC Risperidone Sales Quantity by Company (2018-2023) & (K Units)
Table 89. APAC Risperidone Revenue by Company (2018-2023) & (US$ Million)
Table 90. APAC Risperidone Sales Quantity by Type (2018-2023) & (K Units)
Table 91. APAC Risperidone Sales Quantity by Type (2024-2034) & (K Units)
Table 92. APAC Risperidone Revenue by Type (2018-2023) & (US$ Million)
Table 93. APAC Risperidone Revenue by Type (2024-2034) & (US$ Million)
Table 94. APAC Risperidone Sales Quantity by Application (2018-2023) & (K Units)
Table 95. APAC Risperidone Sales Quantity by Application (2024-2034) & (K Units)
Table 96. APAC Risperidone Revenue by Application (2018-2023) & (US$ Million)
Table 97. APAC Risperidone Revenue by Application (2024-2034) & (US$ Million)
Table 98. APAC Risperidone Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 99. APAC Risperidone Revenue by Region (2018-2023) & (US$ Million)
Table 100. APAC Risperidone Revenue by Region (2024-2034) & (US$ Million)
Table 101. APAC Risperidone Sales Quantity by Region (2018-2023) & (K Units)
Table 102. APAC Risperidone Sales Quantity by Region (2024-2034) & (K Units)
Table 103. Middle East, Africa and Latin America Risperidone Sales Quantity by Company (2018-2023) & (K Units)
Table 104. Middle East, Africa and Latin America Risperidone Revenue by Company (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Risperidone Sales Quantity by Type (2018-2023) & (K Units)
Table 106. Middle East, Africa and Latin America Risperidone Sales Quantity by Type (2024-2034) & (K Units)
Table 107. Middle East, Africa and Latin America Risperidone Revenue by Type (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Risperidone Revenue by Type (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America Risperidone Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East, Africa and Latin America Risperidone Sales Quantity by Application (2024-2034) & (K Units)
Table 111. Middle East, Africa and Latin America Risperidone Revenue by Application (2018-2023) & (US$ Million)
Table 112. Middle East, Africa and Latin America Risperidone Revenue by Application (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Risperidone Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 114. Middle East, Africa and Latin America Risperidone Revenue by Country (2018-2023) & (US$ Million)
Table 115. Middle East, Africa and Latin America Risperidone Revenue by Country (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Risperidone Sales Quantity by Country (2018-2023) & (K Units)
Table 117. Middle East, Africa and Latin America Risperidone Sales Quantity by Country (2024-2034) & (K Units)
Table 118. Pharaonia Pharmaceuticals Company Information
Table 119. Pharaonia Pharmaceuticals Description and Overview
Table 120. Pharaonia Pharmaceuticals Risperidone Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2023)
Table 121. Pharaonia Pharmaceuticals Risperidone Product and Services
Table 122. Pharaonia Pharmaceuticals Risperidone SWOT Analysis
Table 123. Pharaonia Pharmaceuticals Recent Developments
Table 124. Aurobindo Pharma Company Information
Table 125. Aurobindo Pharma Description and Overview
Table 126. Aurobindo Pharma Risperidone Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2023)
Table 127. Aurobindo Pharma Risperidone Product and Services
Table 128. Aurobindo Pharma Risperidone SWOT Analysis
Table 129. Aurobindo Pharma Recent Developments
Table 130. Wellona Pharma Company Information
Table 131. Wellona Pharma Description and Overview
Table 132. Wellona Pharma Risperidone Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2023)
Table 133. Wellona Pharma Risperidone Product and Services
Table 134. Wellona Pharma Risperidone SWOT Analysis
Table 135. Wellona Pharma Recent Developments
Table 136. Hikma Pharmaceuticals Company Information
Table 137. Hikma Pharmaceuticals Description and Overview
Table 138. Hikma Pharmaceuticals Risperidone Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2023)
Table 139. Hikma Pharmaceuticals Risperidone Product and Services
Table 140. Hikma Pharmaceuticals Risperidone SWOT Analysis
Table 141. Hikma Pharmaceuticals Recent Developments
Table 142. Janssen Pharmaceuticals Company Information
Table 143. Janssen Pharmaceuticals Description and Overview
Table 144. Janssen Pharmaceuticals Risperidone Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2023)
Table 145. Janssen Pharmaceuticals Risperidone Product and Services
Table 146. Janssen Pharmaceuticals Risperidone SWOT Analysis
Table 147. Janssen Pharmaceuticals Recent Developments
Table 148. Amneal Pharmaceuticals Company Information
Table 149. Amneal Pharmaceuticals Description and Overview
Table 150. Amneal Pharmaceuticals Risperidone Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2023)
Table 151. Amneal Pharmaceuticals Risperidone Product and Services
Table 152. Amneal Pharmaceuticals Risperidone SWOT Analysis
Table 153. Amneal Pharmaceuticals Recent Developments
Table 154. Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Company Information
Table 155. Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Description and Overview
Table 156. Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Risperidone Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2023)
Table 157. Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Risperidone Product and Services
Table 158. Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Risperidone SWOT Analysis
Table 159. Jilin Xidian Pharmaceutical Sci-Tech Development Co., Ltd. Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Risperidone Distributors List
Table 163. Risperidone Customers List
Table 164. Risperidone Market Trends
Table 165. Risperidone Market Drivers
Table 166. Risperidone Market Challenges
Table 167. Risperidone Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Risperidone Product Picture
Figure 2. Global Risperidone Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Risperidone Market Share by Type in 2024 & 2034
Figure 4. Tablets Product Picture
Figure 5. Solution Product Picture
Figure 6. Others Product Picture
Figure 7. Global Risperidone Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 8. Global Risperidone Market Share by Application in 2024 & 2034
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Risperidone Report Years Considered
Figure 13. Global Risperidone Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Risperidone Revenue 2018-2034 (US$ Million)
Figure 15. Global Risperidone Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 16. Global Risperidone Sales Quantity 2018-2034 (K Units)
Figure 17. Global Risperidone Sales Quantity Market Share by Region (2018-2023)
Figure 18. Global Risperidone Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Risperidone Sales Quantity YoY (2018-2034) & (K Units)
Figure 20. North America Risperidone Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Risperidone Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. Europe Risperidone Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Risperidone Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. China Risperidone Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Risperidone Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. APAC Risperidone Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Risperidone Sales Quantity YoY (2018-2034) & (K Units)
Figure 28. Middle East, Africa and Latin America Risperidone Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Risperidone Sales Quantity in 2024
Figure 30. The Top 10 and Top 5 Players Market Share by Risperidone Revenue in 2024
Figure 31. Risperidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 32. Global Risperidone Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Risperidone Revenue Market Share by Type (2018-2034)
Figure 34. Global Risperidone Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Risperidone Revenue Market Share by Application (2018-2034)
Figure 36. North America Risperidone Revenue Market Share by Company in 2024
Figure 37. North America Risperidone Sales Quantity Market Share by Company in 2024
Figure 38. North America Risperidone Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Risperidone Revenue Market Share by Type (2018-2034)
Figure 40. North America Risperidone Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Risperidone Revenue Market Share by Application (2018-2034)
Figure 42. North America Risperidone Revenue Share by Country (2018-2034)
Figure 43. North America Risperidone Sales Quantity Share by Country (2018-2034)
Figure 44. United States Risperidone Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Risperidone Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Risperidone Sales Quantity Market Share by Company in 2024
Figure 47. Europe Risperidone Revenue Market Share by Company in 2024
Figure 48. Europe Risperidone Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Risperidone Revenue Market Share by Type (2018-2034)
Figure 50. Europe Risperidone Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Risperidone Revenue Market Share by Application (2018-2034)
Figure 52. Europe Risperidone Revenue Share by Country (2018-2034)
Figure 53. Europe Risperidone Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Risperidone Revenue (2018-2034) & (US$ Million)
Figure 55. France Risperidone Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Risperidone Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Risperidone Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Risperidone Revenue (2018-2034) & (US$ Million)
Figure 59. China Risperidone Sales Quantity Market Share by Company in 2024
Figure 60. China Risperidone Revenue Market Share by Company in 2024
Figure 61. China Risperidone Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Risperidone Revenue Market Share by Type (2018-2034)
Figure 63. China Risperidone Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Risperidone Revenue Market Share by Application (2018-2034)
Figure 65. APAC Risperidone Sales Quantity Market Share by Company in 2024
Figure 66. APAC Risperidone Revenue Market Share by Company in 2024
Figure 67. APAC Risperidone Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Risperidone Revenue Market Share by Type (2018-2034)
Figure 69. APAC Risperidone Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Risperidone Revenue Market Share by Application (2018-2034)
Figure 71. APAC Risperidone Revenue Share by Region (2018-2034)
Figure 72. APAC Risperidone Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Risperidone Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Risperidone Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Risperidone Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Risperidone Revenue (2018-2034) & (US$ Million)
Figure 77. India Risperidone Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Risperidone Sales Quantity Market Share by Company in 2024
Figure 79. Middle East, Africa and Latin America Risperidone Revenue Market Share by Company in 2024
Figure 80. Middle East, Africa and Latin America Risperidone Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Risperidone Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Risperidone Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Risperidone Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Risperidone Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Risperidone Revenue Share by Country (2018-2034)
Figure 86. Brazil Risperidone Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Risperidone Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Risperidone Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Risperidone Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Risperidone Revenue (2018-2034) & (US$ Million)
Figure 91. Risperidone Value Chain
Figure 92. Risperidone Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries